The relationship between golfing and the cannabidiol (CBD) industry took another step forward on Tuesday (January 21) as a producer was tapped as a sponsor for an upcoming tournament.

The Farmers Insurance Open, an official tournament that is part of the PGA Golf tour, confirmed CV Sciences’ (OTCQB:CVSI) PlusCBD Oil brand of products as a sponsor of the event.


The tournament, which starts this Thursday (January 23) at Torrey Pines in San Diego, California, will attract some of the top talent the PGA has to offer as it is one of the first big events of the golf season.

“We believe both professional and amateur golfers can benefit from PlusCBD Oil products and we look forward to increasing our visibility among the golf community through this sponsorship,” Joseph Dowling, CEO of CV Sciences, said in a statement.

For the CBD producer, this marks a critical development in the adoption of CBD as part of professional athletes’ everyday routines. Particularly, golfing has become a proponent of CBD use among active players.

According to CV Sciences, golf players have picked up CBD use as a way to engage with recovery in terms of general aches and pains to the body, and also as a way to help with muscle relaxation.

In addition to the general sponsorship agreement, the CBD producer will maintain a booth for attendants of the tournament.

The CBD industry has only been upgrading its ties with the sport of golf recently. Last year, cbdMD (NYSEAMERICAN:YCBD) inked a sponsor partnership with professional golfer Bubba Watson. The player agreed to incorporate the logo of the company as part of his official playing attire.

The decision from Watson did not come as a surprise as many players have embraced the potential attached to CBD for their own recoveries. In an ESPN report, players outlined how using CBD has changed their health patterns.

“The players are comfortable with a low THC count. That was the main thing I had a hesitancy about, what is their response to putting something in their bodies that’s new? …” Steve Patterson, director of sales at Functional Remedies EndoSport, told ESPN. “But it’s also a natural product, so then word of mouth, it really took off. That’s where the popularity and acceptance has come in.”

Last year, Functional Remedies EndoSport touted having nearly 100 professional golf players under its sponsor umbrella.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

Global Wellness Strategies Inc. (formerly Redfund Capital Corp.) (CSE: LOAN) (FSE: O3X4) (OTCQB: PNNRD) (“Global” or the “Company”) announces it has signed a binding letter of intent (“BLOI”) on January 22, 2021 with EntheoTech Bioscience Inc. (“ET”) a wellness psilocybin leader based in Kelowna, British Columbia and will have the option to earn up to a 19.9% interest in ET.

EntheoTech is a Canadian bioscience company focused on the research and development of products, and protocols to promote brain health, performance optimization, and global wellness, using psychoactive substances such as psilocybin, medicinal mushrooms, and other natural products.

Keep reading... Show less

The new dispensary brings expanded access for patients along Florida’s Atlantic Coast

Trulieve Cannabis Corp. (CSE: TRUL)  (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of a brand-new Florida dispensary, the Company’s 78th nationwide. The new 4,600 sq. ft. location marks the Company’s first in the city of Sebastian and second in Indian River county expanding patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.

Keep reading... Show less

Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (NASDAQ: CGC) will release its financial results for the third quarter fiscal 2021 ended December 31, 2020 before financial markets open on February 9, 2021.

Keep reading... Show less

NYSE | TSX: ACB

Aurora Cannabis Inc. (the “Company” or “Aurora”) (NYSE: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today the closing of its previously announced bought deal public offering (the “Offering”) of units of the Company (the “Units”) for total gross proceeds of US$137,940,000 . The Company sold 13,200,000 Units at a price of US$10.45 per Unit, including 1,200,000 Units sold pursuant to the exercise in full of the underwriters’ over-allotment option.

Keep reading... Show less

Aurora Cannabis Inc. (the “Company” or “Aurora”) (NYSE | TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today the closing of its previously announced bought deal public offering (the “Offering”) of units of the Company (the “Units”) for total gross proceeds of US$137,940,000. The Company sold 13,200,000 Units at a price of US$10.45 per Unit, including 1,200,000 Units sold pursuant to the exercise in full of the underwriters’ over-allotment option.

Each Unit is comprised of one common share of the Company (a “Common Share”) and one half of one common share purchase warrant of the Company (each full common share purchase warrant, a “Warrant”). Each Warrant is exercisable to acquire one common share of the Company (a “Warrant Share”) for a period of 36 months following the closing date of the Offering at an exercise price of US$12.60 per Warrant Share, subject to adjustment in certain events.

Keep reading... Show less